Our Representative Director and CEO, Dr. Shingo Nakamura, and our Chief Scientific Officer, Dr. Ella Morishita, joined BIO-Europe 2024, held in Stockholm, Sweden, from November 4 to 6, 2024. During the event, they introduced our platform technology to pharmaceutical companies from the EU and US.

Dr. Morishita also delivered a presentation on the potential of mRNA-targeted small molecule drug discovery, a promising new paradigm for the pharmaceutical industry, and how our drug discovery technology enables this approach. We would like to express our sincere gratitude to everyone who attended Dr. Morishita’s talk at BIO-Europe.

The presentation material from Dr. Morishita’s talk is available at the link below.
BIO-Europe Presentation (November 4, 2024)